ALLIANCE A031501

Primary Category:

Treatment Protocols

Disease Category:

Bladder, Genitourinary

Status:

Open, Temporarily Closed

Phase III Randomized Adjuvant study of MK-3475 (Pembrolizumab) in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation

NCT#03244384

Eligible for screening study DCP 001

A031501 is temporarily closed to new patient accrual pending implementation of Update 8 revised documents, effective July 6, 2021.